Startups

PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.

Summary

Seedtable Score
  • 17
Locations
Company Size
  • 11 to 50 employees
Last Stage Round
  • Unknown

Total funding Amount

$6.4M

Fundraising History

  • Jun 01 '22 Unknown
    $3M
  • Oct 01 '20 Unknown
    $2M

Investors

  • Parkwalk Advisors
    Unknown
  • Martlet Capital
    Unknown